全球缺血再灌流傷害治療市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，缺血再灌流傷害治療市場規模將從 2025 年的 32.7 億美元成長至 45.9 億美元，並預計從 2026 年到 2034 年將以 3.84% 的複合年成長率成長。

由於心血管疾病、中風和器官移植手術的增加，全球缺血再灌流傷害治療市場正在擴張。缺血再灌流傷害是指組織在長時間缺氧後恢復供血時所發生的傷害。心臟病發作和手術次數的增加推動了對有效治療方案的需求。

人們對心血管疾病早期診斷和治療重要性的認知不斷提高，是推動該市場發展的主要因素。藥物研發和標靶治療的進步也正在改善治療效果。政府主導的各項措施以及已開發國家和開發中國家醫療保健支出的增加，進一步促進了市場成長。

未來幾年，對抗氧化劑和生物製藥等創新治療方法的研究將帶來廣泛的機會。人們日益關注改善術後復健和減少併發症，這將支撐市場需求。隨著臨床研究的不斷深入，缺血再灌流傷害治療市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球缺血再灌流傷害治療市場：依治療方法分類

• 市場分析、洞察與預測
• 藥物治療
• 醫用氣體
• 其他

第5章：全球缺血再灌流傷害治療市場：依傷害類型分類

• 市場分析、洞察與預測
• 心臟損傷
• 腎損傷
• 腸道損傷
• 其他

第6章：全球缺血再灌流傷害治療市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 其他

第7章 全球缺血再灌流傷害治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Amyndas Pharmaceuticals LLC
  • Angion
  • Bolder Biotechnology
  • Opsona Therapeutics Ltd
  • Pharming Group NV
  • Prolong Pharmaceuticals
  • Prothix BV
  • Stealth BioTherapeutics Inc
  • Zealand Pharma A/S
  • Faraday Pharmaceuticals
  • SBI Pharmaceuticals

The Ischemia Reperfusion Injury Therapeutics Market size is expected to reach USD 4.59 Billion in 2034 from USD 3.27 Billion (2025) growing at a CAGR of 3.84% during 2026-2034.

The Global Ischemia Reperfusion Injury Therapeutics Market is expanding due to the increasing prevalence of cardiovascular diseases, stroke, and organ transplantation procedures. Ischemia reperfusion injury occurs when blood supply returns to tissues after a period of oxygen deprivation, causing further damage. The growing number of heart attacks and surgical interventions has increased the need for effective therapeutic solutions.

Rising awareness about early diagnosis and treatment of cardiovascular conditions is a key driver for this market. Advances in drug development and targeted therapies are also improving treatment outcomes. Government initiatives and increased healthcare spending in both developed and developing regions further contribute to market growth.

In the coming years, research into innovative therapies such as antioxidant drugs and biologics will create promising opportunities. The increasing focus on improving post-surgical recovery and reducing complications will support demand. As clinical research continues to expand, the market for ischemia reperfusion injury therapeutics is expected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment

• Drug Therapy
• Medicated Gases
• Others

By Injury Type

• Heart Injury
• Kidney Injury
• Intestine Injury
• Others

By End-user

• Hospitals
• Specialty Clinics
• Others

COMPANIES PROFILED

• Amyndas Pharmaceuticals LLC, Angion, Bolder Biotechnology, Opsona Therapeutics Ltd, Pharming Group NV, Prolong Pharmaceuticals, Prothix BV, Stealth BioTherapeutics Inc, Zealand Pharma AS, Faraday Pharmaceuticals, SBI Pharmaceuticals
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ISCHEMIA REPERFUSION INJURY THERAPEUTICS MARKET: BY TREATMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Treatment
• 4.2. Drug Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Medicated Gases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ISCHEMIA REPERFUSION INJURY THERAPEUTICS MARKET: BY INJURY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Injury Type
• 5.2. Heart Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Kidney Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Intestine Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ISCHEMIA REPERFUSION INJURY THERAPEUTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ISCHEMIA REPERFUSION INJURY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Treatment
  • 7.2.2 By Injury Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Treatment
  • 7.3.2 By Injury Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Treatment
  • 7.4.2 By Injury Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Treatment
  • 7.5.2 By Injury Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Treatment
  • 7.6.2 By Injury Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ISCHEMIA REPERFUSION INJURY THERAPEUTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Amyndas Pharmaceuticals LLC
  • 9.2.2 Angion
  • 9.2.3 Bolder Biotechnology
  • 9.2.4 Opsona Therapeutics Ltd
  • 9.2.5 Pharming Group NV
  • 9.2.6 Prolong Pharmaceuticals
  • 9.2.7 Prothix BV
  • 9.2.8 Stealth BioTherapeutics Inc
  • 9.2.9 Zealand Pharma A/S
  • 9.2.10 Faraday Pharmaceuticals
  • 9.2.11 SBI Pharmaceuticals